Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

More documents

Recommendations

Info

cancer and brain metastases. J Clin Oncol 2009;27:5255-5261.530 - Socinski MASocinski MA, Schell MJ, Peterman A, et al. Phase III trial comparing a defined duration of therapy versuscontinuous therapy followed by second line therapy in advanced-stage IIIB/IV non–small-cell lung cancer. JClin Oncol 20:1335-1343, 2002.531 - Solis LMSolis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CA. Primary oncocytic adenocarcinomas ofthe lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J ClinPathol 133:133-140, 2010.532 - Soon YYSoon YY, Stockler MR, Askie LM, Boyer MJ. Duration of chemotherapy for advanced non–small-cell lungcancer: A systematic review and meta-analysis of randomized trials. J Clin Oncol 2009;27; 3277-3283.533 - Soorae ASSoorae AS, Stevenson HM. Survival with residual tumor on the bronchial margin after resection forbronchogenic carcinoma. J Thorac Cardiovasc Surg 78:175-180, 1979.534 - Soresi ESoresi E, Clerici M, Grilli R, Borghini U, Zucali R, Leoni M, et al. A randomized clinical trial comparingradiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locallyadvanced non-small cell lung cancer. Semin Oncol 15(Suppl 7):20-25, 1988535 - Spiro SGSpiro SG, Rudd RM, Souhami RL, Brown RL, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V,Parmar MKB, Peake MD, Stephens RJ, Thorpe H, Waller DA, West P, on behalf of all the Big Lung Trialparticipants. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improvedsurvival without detriment to quality of life. Thorax 59:828-836, 2004.536 - Strauss GMStrauss GM, Herndon JE, II, Maddaus MA, Johnstone DW, et al. Adjuvant Paclitaxel Plus CarboplatinCompared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer andLeukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group StudyGroups. J Clin Oncol 26:5043-5051, 2008.537 - Sugi KSugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection forclinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg;22:290-294, 1998.538 - Sun LMSun LM, Leung SW, Wang CJ, Chen HC, Fang FM, Huang EY, et al. Concomitant boost radiation therapyfor inoperable non-small-cell lung cancer: preliminary report of a prospective randomized study. Int J RadiatOncol Biol Phys 47:41341-8. 2000.539 - Sunaga NSunaga N, Tomizawa Y, Yanagitani N, et al. Phase II prospective study of the efficacy of gefitinib for thetreatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previouschemotherapy. Lung Cancer 56:383-389, 2007.540 - Sutani ARichtlijn: Niet-kleincellig longcarcinoom (2.0)Sutani A, Nagai Y, Udagawa K, et al. Gefitinib for non-small-cell lung cancer patiënts with epidermal growthfactor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp. Br JCancer 95:1483-1489, 2006.541 - Swensen SJSwensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary06/09/2011 Niet-kleincellig longcarcinoom (2.0) 133
pulmonary nodules. Application to small radiologically indeterminate nodules. Arch. Szlubowski et al. Acombined approach of endobronchial and endoscopic ultrasound guided needle aspiration in theradiologically normal mediastinumin NSCLC staging – a prospective trail. Eur J Cardiothoracic Surg 2009,dec 18, epub.542 - Takamochi KTakamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, et al. Pitfalls in lymph node stagingwith positron emission tomography in non-small cell lung cancer patiënts. Lung Cancer 47:235-242, 2005.543 - Takeda KTakeda K, Hida T, Sato T, et al. Randomzed phase III trial of platinum-doublet chemotherapy followed bygefitinib compared with continued platinum-doublet chemotherapy in Japanese patiënts with advancednon-small-cell lung cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203). J ClinOncol 28:753-760;2010.544 - Takizawa TTakizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph nodemetastasis in patiënts with clinical stage I peripheral non-small cell lung cancer. J Thorac Cardiovasc Surg113:248-252, 1997.545 - Talebian MTalebian M, von Bartheld MB, Braun J, Versteegh MI, Dekkers OM, Rabe KF, et al. EUS-FNA in thepreoperative staging of non-small cell lung cancer. Lung Cancer 2009 Sep 14.546 - Tamura KTamura K, Okamoto I, Kashii T, et al. Multicentre prospective phase II trial of gefitinib for advancednon-small cell lung cancer with epidermal growth factor receptor mutations: results of the West JapanThoracic Oncology Group trial (WJTOG0403). Br. J. Cancer 98:907-914, 2008.547 - Tatematsu ATatematsu A, Shimizu J, Murakami Y, et al. Epidermal growth factor receptor mutations in small cell lungcancer. Clin Cancer Res 14:6092-6096, 2008.548 - Tedder MTedder M, Anstadt MP, Tedder SD, Lowe JE. Current morbidity, mortality and survival after bronchoplasticprocedures for malignancy.Ann Thorac Surg 54:387-391, 1992.549 - Temeck BKTemeck BK, Schafer PW, Saini N. Wedge resection for bronchogenic carcinoma in high-risk patiënts.South Med J 85:1-10, 1992.550 - Terzi ATerzi A, Lonardoni A, Falezza G, et al. ‘sleeve’-lobectomy for non-small cell lung cancer and carcinoids:results in 160 cases.Eur J Cardiothorac Surg 21:888-893, 2002.551 - Teshima TTeshima T, Inoue T, Inoue T, Ikeda H, Marayama S, Yamazaki H, et al. Symptomatic relief for patiënts withosseous metastases treated with radiation and methylprednisolone: a prospective randomised study.Radiat Med 17:411-416, 1996.552 - Thatcher NThatcher N, Chang A,Parikh P, et al. Gefitinib plus best supportive care in previously treated patiënts withrefractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentrestudy (Iressa Survival Evaluation in Lung Cancer). Lancet 366: 1527–1537, 2005.553 - The Canadian Lung Oncology GroupThe Canadian Lung Oncology Group. Investigating extrathoracic metastatic disease in patiënts withapparently operable lung cancer. Ann Thorac Surg 71:425-434, 2001.554 - The Canadian Lung Oncology GroupRichtlijn: Niet-kleincellig longcarcinoom (2.0)06/09/2011 Niet-kleincellig longcarcinoom (2.0) 134
Page 6 and 7:
ScreeningLiteratuurbespreking:De wa
Page 8 and 9:
DiagnostiekLiteratuurbespreking:Dit
Page 10 and 11:
Richtlijn: Niet-kleincellig longcar
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
komen in aanmerking voor een medias
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
PathologiediagnostiekUitgangsvraagW
Page 26 and 27:
Page 28 and 29:
Resectabel en lokaal uitgebreid NSC
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
2.Richtlijn: Niet-kleincellig longc
Page 38 and 39:
cytologischonderzoek(depschrapprepa
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Systemische behandeling stadium III
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
de progressievrije overleving en ee
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Palliatieve zorgLiteratuurbesprekin
Page 70 and 71:
Voorlichting en communicatieLiterat
Page 72 and 73:
Nacontrole en nazorgAanbevelingen:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
PatiëntendossierRichtlijn: Niet-kl
Page 84 and 85:
BehandelingOver de behandeling die
Page 86 and 87: Rol van de verpleegkundigeRichtlijn
Page 88 and 89: Richtlijn: Niet-kleincellig longcar
Page 90 and 91: TNM classificatieAanbevelingen:De n
Page 92 and 93: 1. Pleurale en pericardiale effusie
Page 96 and 97: Referenties1 - A. AupérinA. Aupér
Page 98 and 99: 26 - Asamura HAsamura H, Naruke T,
Page 102 and 103: Cappuzzo F, Marchetti A, Skokan M,
Page 112 and 113: comparative analysis of positron em
Page 116 and 117: accuracy and quality control. Am J
Page 142 and 143: lung cancer: A secondary analysis o
Page 144 and 145: Early-Stage Non-Small-Cell Lung Can
Page 146 and 147: Bijlagen1. Betrokken verenigingenIn
Page 148 and 149: • Hr. drs. H.E. Codrington, longa
Page 150 and 151: aanbevolen bijNSCLC-patiënten,stad
Page 152 and 153: med 090318 vr1 diagnostiek PET etc
Page 158 and 159: Mackillop vergelijkend (tussen alle
Page 160: DisclaimerDisclaimer:De informatie
show all

Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

Create successful ePaper yourself

Delete template?

Save as template?